Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Shienbaum

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Retina (Philadelphia, Pa.)|April 11, 2006
Coats disease: a lifetime diseaseGary Shienbaum, William S Tasman
Retinal Cases & Brief Reports|November 13, 2014
Orbital hemorrhage after intravitreal injectionGary Shienbaum, Richard S Kaiser, Scott M Goldstein
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Hypopyon and pseudoendophthalmitis 1 month after vitrectomy for retinal detachment with subretinal hemorrhageZayna Nahas, Gary Shienbaum, William E Smiddy, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 20, 2013
Evolving strategies in the management of diabetic macular edema: clinical trials and current managementBenjamin J Thomas, Gary Shienbaum, David S Boyer, et al.
Retinal Cases & Brief Reports|November 13, 2014
Neovascular glaucoma as the presenting sign of metastatic small cell lung carcinomaChirag P Shah, Gary Shienbaum, Carol L Shields, et al.
American Journal of Ophthalmology|October 15, 2011
Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impactGary Shienbaum, Omesh P Gupta, Christopher Fecarotta, et al.
Ophthalmology|July 2, 2010
A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impactOmesh P Gupta, Gary Shienbaum, Avni H Patel, et al.
American Journal of Ophthalmology|March 8, 2013
Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapyGary Shienbaum, Carlos Alexandre A Garcia Filho, Harry W Flynn, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Retina (Philadelphia, Pa.)|April 11, 2006
Coats disease: a lifetime diseaseGary Shienbaum, William S Tasman
Retinal Cases & Brief Reports|November 13, 2014
Orbital hemorrhage after intravitreal injectionGary Shienbaum, Richard S Kaiser, Scott M Goldstein
Ophthalmic Surgery, Lasers & Imaging Retina|May 17, 2013
Hypopyon and pseudoendophthalmitis 1 month after vitrectomy for retinal detachment with subretinal hemorrhageZayna Nahas, Gary Shienbaum, William E Smiddy, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 20, 2013
Evolving strategies in the management of diabetic macular edema: clinical trials and current managementBenjamin J Thomas, Gary Shienbaum, David S Boyer, et al.
Retinal Cases & Brief Reports|November 13, 2014
Neovascular glaucoma as the presenting sign of metastatic small cell lung carcinomaChirag P Shah, Gary Shienbaum, Carol L Shields, et al.
American Journal of Ophthalmology|October 15, 2011
Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impactGary Shienbaum, Omesh P Gupta, Christopher Fecarotta, et al.
Ophthalmology|July 2, 2010
A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impactOmesh P Gupta, Gary Shienbaum, Avni H Patel, et al.
American Journal of Ophthalmology|March 8, 2013
Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapyGary Shienbaum, Carlos Alexandre A Garcia Filho, Harry W Flynn, et al.
Pageof 1